• 1
    Swain, S. L., McKinstry, K. K. and Strutt, T. M., Expanding roles for CD4(+) T cells in immunity to viruses. Nat. Rev. Immunol. 2012. 12: 136148.
  • 2
    Sparks-Thissen, R. L., Braaten, D. C., Kreher, S., Speck, S. H. and Virgin, H. W. 4th, An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J. Virol. 2004. 78: 68276835.
  • 3
    Johnson, A. J., Chu, C. F. and Milligan, G. N., Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J. Virol. 2008. 82: 96789688.
  • 4
    Ishikawa, T., Yamada, H., Oyamada, A., Goshima, F., Nishiyama, Y. and Yoshikai, Y., Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice. J. Virol. 2009. 83: 1177711783.
  • 5
    Teijaro, J. R., Verhoeven, D., Page, C. A., Turner, D. and Farber, D. L., Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J. Virol. 2010. 84: 92179226.
  • 6
    Britt, W., Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 2008. 325: 417470.
  • 7
    Krmpotic, A., Bubic, I., Polic, B., Lucin, P. and Jonjic, S., Pathogenesis of murine cytomegalovirus infection. Microbes Infect. 2003. 5: 12631277.
  • 8
    Crough, T. and Khanna, R., Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 2009. 22: 7698.
  • 9
    Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. and Greenberg, P. D., Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992. 257: 238241.
  • 10
    Gamadia, L. E., Rentenaar, R. J., van Lier, R. A. and ten Berge, I. J., Properties of CD4(+) T cells in human cytomegalovirus infection. Hum. Immunol. 2004. 65: 486492.
  • 11
    Tu, W., Chen, S., Sharp, M., Dekker, C., Manganello, A. M., Tongson, E. C., Maecker, H. T. et al., Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 2004. 172: 32603267.
  • 12
    Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D. and Riddell, S. R., Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 1995. 333: 10381044.
  • 13
    Gerna, G., Lilleri, D., Fornara, C., Comolli, G., Lozza, L., Campana, C., Pellegrini, C. et al., Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation. Am. J. Transplant. 2006. 6: 23562364.
  • 14
    Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U. et al., Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002. 99: 39163922.
  • 15
    Jonjic, S., Pavic, I., Lucin, P., Rukavina, D. and Koszinowski, U. H., Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J. Virol. 1990. 64: 54575464.
  • 16
    Walton, S. M., Mandaric, S., Torti, N., Zimmermann, A., Hengel, H. and Oxenius, A., Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog. 2011. 7: e1002214.
  • 17
    Walton, S. M., Wyrsch, P., Munks, M. W., Zimmermann, A., Hengel, H., Hill, A. B. and Oxenius, A., The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J. Immunol. 2008. 181: 11281134.
  • 18
    Mandaric, S., Walton, S. M., Rulicke, T., Richter, K., Girard-Madoux, M. J., Clausen, B. E., Zurunic, A. et al., IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. PLoS Pathog. 2012. 8: e1002846.
  • 19
    Frebel, H., Richter, K. and Oxenius, A., How chronic viral infections impact on antigen-specific T-cell responses. Eur. J. Immunol. 2010. 40: 654663.
  • 20
    Zelinskyy, G., Myers, L., Dietze, K. K., Gibbert, K., Roggendorf, M., Liu, J., Lu, M. et al., Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J. Immunol. 2011. 187: 37303737.
  • 21
    Brown, K. E., Freeman, G. J., Wherry, E. J. and Sharpe, A. H., Role of PD-1 in regulating acute infections. Curr. Opin. Immunol. 2010. 22: 397401.
  • 22
    Marshall, H. D., Chandele, A., Jung, Y. W., Meng, H., Poholek, A. C., Parish, I. A., Rutishauser, R. et al., Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. Immunity 2011. 35: 633646.
  • 23
    Hegde, N. R., Dunn, C., Lewinsohn, D. M., Jarvis, M. A., Nelson, J. A. and Johnson, D. C., Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4 +CTL. J. Exp. Med. 2005. 202: 11091119.
  • 24
    Steffens, H. P., Kurz, S., Holtappels, R. and Reddehase, M. J., Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J. Virol. 1998. 72: 17971804.
  • 25
    Holtappels, R., Bohm, V., Podlech, J. and Reddehase, M. J., CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model. Med. Microbiol. Immunol. 2008. 197: 125134.
  • 26
    Torti, N., Walton, S. M., Brocker, T., Rulicke, T. and Oxenius, A., Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog. 2011. 7: e1002313.
  • 27
    Kutok, J. L. and Wang, F., Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 2006. 1: 375404.
  • 28
    Clark, D. A., Emery, V. C. and Griffiths, P. D., Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. Semin. Hematol. 2003. 40: 154162.
  • 29
    Baldassano, V., Dunn, J. P., Feinberg, J. and Jabs, D. A., Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N. Engl. J. Med. 1995. 333: 670.
  • 30
    Hata, A., Asanuma, H., Rinki, M., Sharp, M., Wong, R. M., Blume, K. and Arvin, A. M., Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N. Engl. J. Med. 2002. 347: 2634.
  • 31
    Blyth, E., Gaundar, S. S., Clancy, L., Simms, R. M., Bilmon, I., Micklethwaite, K. P. and Gottlieb, D. J., Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients. Cytotherapy 2012. 14: 724732.
  • 32
    Haque, T., Wilkie, G. M., Jones, M. M., Higgins, C. D., Urquhart, G., Wingate, P., Burns, D. et al., Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 2007. 110: 11231131.
  • 33
    Reddehase, M. J., Jonjic, S., Weiland, F., Mutter, W. and Koszinowski, U. H., Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J. Virol. 1988. 62: 10611065.
  • 34
    Rentenaar, R. J., Gamadia, L. E., van DerHoek, N., van Diepen, F. N., Boom, R., Weel, J. F., Wertheim-van Dillen, P. M. et al., Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J. Clin. Invest. 2000. 105: 541548.
  • 35
    van Leeuwen, E. M., Remmerswaal, E. B., Vossen, M. T., Rowshani, A. T., Wertheim-van Dillen, P. M., van Lier, R. A. and ten Berge, I. J., Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 2004. 173: 18341841.
  • 36
    Sellar, R. S. and Peggs, K. S., Therapeutic strategies for the prevention and treatment of cytomegalovirus infection. Expert Opin. Biol. Ther. 2012. 12: 11611172.
  • 37
    Antoine, P., Olislagers, V., Huygens, A., Lecomte, S., Liesnard, C., Donner, C. and Marchant, A., Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection. J. Immunol. 2012. 189: 26652672.
  • 38
    Gamadia, L. E., Remmerswaal, E. B., Weel, J. F., Bemelman, F., van Lier, R. A. and Ten Berge, I. J., Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003. 101: 26862692.
  • 39
    Akulian, J. A., Pipeling, M. R., John, E. R., Orens, J. B., Lechtzin, N. and McDyer, J. F., High-quality CMV-specific CD4(+) memory is enriched in the lung allograft and is associated with mucosal viral control. Am. J. Transplant. 2012. 13: 146156.
  • 40
    Brune, W., Hengel, H. and Koszinowski, U. H., A mouse model for cytomegalovirus infection. Curr. Protoc. Immunol. 2001. Chapter 19: Unit 19.7.
  • 41
    Joller, N., Sporri, R., Hilbi, H. and Oxenius, A., Induction and protective role of antibodies in Legionella pneumophila infection. Eur. J. Immunol. 2007. 37: 34143423.